ELIM Rheumatic Centre, 03 May 2017 Namilumab (AMG203) is an immunoglobulin G1 monoclonal antibody that binds with high affinity to the GM-CSF ligand. This was a…
My Rheumatology, 11 Mar 2017 Anti GM-CSF is promising in #RA. #namilumab We now need superior efficacy to existing therapies. Phase 2 in progress.